BioWorld Asia

July 9, 2008

European Biotech Industry Sets Out Tough Agenda

BRUSSELS, Belgium - The European biotech industry is facing a long list of unmet priority tasks, according to its just-released 2008 annual report. (BioWorld International) Read More

Shire Paying Jerini $519M for HAE Compound Firazyr

SkyPharma's Flutiform Meets Endpoint in 3rd Phase III Trial

Study Boosts Serotonin Theory for Crib Death

Cellectis, Regeneron Settle Licensing Disagreement

ExonHit Attacking Alzheimer's in Therapeutic, Diagnostics

MediGene's RhuDex on Hold After Death of Trial Volunteer

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

Businesspeople shaking hands, meeting with cityscape, charts

Deals and an M&A strengthen end-of-year numbers

BioWorld

Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...

Neutrophils put the brakes on fat loss

BioWorld Science

Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...